Molecular and genomic approach for understanding the gene-environment interaction between Nrf2 deficiency and carcinogenic nickel-induced DNA damage

Kim,Hye  Lim; Seo,Young  Rok

doi:10.3892/or.2012.2057

Molecular and genomic approach for understanding the gene-environment interaction between Nrf2 deficiency and carcinogenic nickel-induced DNA damage

Authors:
- Hye Lim Kim
- Young Rok Seo
View Affiliations

Affiliations: Department of Life Science, Dongguk University, Jung-gu, Seoul 100-715, Republic of Korea
Published online on: September 26, 2012 https://doi.org/10.3892/or.2012.2057
Pages: 1959-1967
Copyright: © Kim et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Nickel (Ⅱ) is a toxic and carcinogenic metal which induces a redox imbalance following oxidative stress. Nuclear factor erythroid-2 related factor 2 (Nrf2) is a redox factor that regulates oxidation/reduction status and consequently mediates cytoprotective responses against exposure to environmental toxicants. In this study, we investigated the protective roles of the Nrf2 gene against oxidative stress and DNA damage induced by nickel at sub-lethal doses. Under nickel exposure conditions, we detected significantly increased intracellular ROS generation, in addition to higher amounts of DNA damage using comet assay and γ-H2AX immunofluorescence staining in Nrf2 lacking cells, as compared to Nrf2 wild-type cells. In addition, we attempted to identify potential nickel and Nrf2-responsive targets and the relevant pathway. The genomic expression data were analyzed using microarray for the selection of synergistic effect-related genes by Nrf2 knockdown under nickel treatment. In particular, altered expressions of 6 upregulated genes (CAV1, FOSL2, MICA, PIM2, RUNX1 and SLC7A6) and 4 downregulated genes (APLP1, CLSPN, PCAF and PRAME) were confirmed by qRT-PCR. Additionally, using bioinformatics tool, we found that these genes functioned principally in a variety of molecular processes, including oxidative stress response, necrosis, DNA repair and cell survival. Thus, we describe the potential biomarkers regarded as molecular candidates for Nrf2-related cellular protection against nickel exposure. In conclusion, these findings indicate that Nrf2 is an important factor with a protective role in the suppression of mutagenicity and carcinogenicity by environmental nickel exposure in terms of gene-environment interaction.

View Figures

View References

1	Kasprzak KS, Sunderman FW Jr and Salnikow K: Nickel carcinogenesis. Mutat Res. 533:67–97. 2003. View Article : Google Scholar : PubMed/NCBI
2	Kasprzak KS: Possible role of oxidative damage in metal-induced carcinogenesis. Cancer Invest. 13:411–430. 1995. View Article : Google Scholar : PubMed/NCBI
3	Lynn S, Yew FH, Chen KS and Jan KY: Reactive oxygen species are involved in nickel inhibition of DNA repair. Environ Mol Mutagen. 29:208–216. 1997. View Article : Google Scholar : PubMed/NCBI
4	Aust AE and Eveleigh JF: Mechanisms of DNA oxidation. Proc Soc Exp Biol Med. 222:246–252. 1999. View Article : Google Scholar
5	Chakrabarti SK, Bai C and Subramanian KS: DNA-protein crosslinks induced by nickel compounds in isolated rat lymphocytes: role of reactive oxygen species and specific amino acids. Toxicol Appl Pharmacol. 170:153–165. 2001. View Article : Google Scholar : PubMed/NCBI
6	Chen XL and Kunsch C: Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. Curr Pharm Des. 10:879–891. 2004. View Article : Google Scholar : PubMed/NCBI
7	Nguyen T, Nioi P and Pickett CB: The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem. 284:13291–13295. 2009. View Article : Google Scholar : PubMed/NCBI
8	Park JY and Seo YR: Enhancement of mitomycin C-induced apoptosis in Nrf2-deficient human colon cancer cells. Mol Cell Toxicol. 6:51–56. 2010. View Article : Google Scholar
9	Giudice A and Montella M: Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention. Bioessays. 28:169–181. 2006. View Article : Google Scholar : PubMed/NCBI
10	Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P and Kensler TW: Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA. 98:3410–3415. 2001. View Article : Google Scholar
11	Osburn WO and Kensler TW: Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults. Mutat Res. 659:31–39. 2008. View Article : Google Scholar : PubMed/NCBI
12	Park JY and Seo YR: The protective role of Nrf2 in cadmium-induced DNA damage. Mol Cell Toxicol. 7:61–66. 2011. View Article : Google Scholar
13	d’Errico A, Malats N, Vineis P and Boffetta P: Review of studies of selected metabolic polymorphisms and cancer. IARC Sci Publ. 148:323–393. 1999.PubMed/NCBI
14	Masuko H, Sakamoto T, Kaneko Y, et al: An interaction between Nrf2 polymorphisms and smoking status affects annual decline in FEV1: a longitudinal retrospective cohort study. BMC Med Genet. 20:12–97. 2011.PubMed/NCBI
15	Koizumi S and Yamada H: DNA microarray analysis of altered gene expression in cadmium-exposed human cells. J Occup Health. 45:331–334. 2003. View Article : Google Scholar : PubMed/NCBI
16	Carinci F, Pezzetti F, Volinia S, Francioso F, Arcelli D, Farina E and Piattelli A: Zirconium oxide: analysis of MG63 osteoblast-like cell response by means of a microarray technology. Biomaterials. 25:215–228. 2004. View Article : Google Scholar : PubMed/NCBI
17	Boverhof DR and Zacharewski TR: Toxicogenomics in risk assessment: applications and needs. Toxicol Sci. 89:352–360. 2006. View Article : Google Scholar : PubMed/NCBI
18	Werner T: Bioinformatics applications for pathway analysis of microarray data. Curr Opin Biotechnol. 19:50–54. 2008. View Article : Google Scholar : PubMed/NCBI
19	Snow ET: Metal carcinogenesis: mechanistic implications. Pharmacol Ther. 53:31–65. 1992. View Article : Google Scholar : PubMed/NCBI
20	Ercal N, Gurer-Orhan H and Aykin-Burns N: Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem. 1:529–539. 2001. View Article : Google Scholar : PubMed/NCBI
21	Singh NP, McCoy MT, Tice RR and Schneider EL: A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 175:184–191. 1988. View Article : Google Scholar
22	Peng X, Wood CL, Blalock EM, Chen KC, Landfield PW and Stromberg AJ: Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics. 4:1–9. 2003. View Article : Google Scholar : PubMed/NCBI
23	Nikitin A, Egorov S, Daraselia N and Mazo I: Pathway studio - the analysis and navigation of molecular networks. Bioinformatics. 19:2155–2157. 2003. View Article : Google Scholar : PubMed/NCBI
24	Sunderman FW Jr, Dingle B, Hopfer SM and Swift T: Acute nickel toxicity in electroplating workers who accidently ingested a solution of nickel sulfate and nickel chloride. Am J Ind Med. 14:257–266. 1988. View Article : Google Scholar : PubMed/NCBI
25	Chen CY, Su YJ, Wu PF and Shyu MM: Nickel-induced plasma lipid peroxidation and effect of antioxidants in human blood: involvement hydroxyl radical formation and depletion of alpha-tocopherol. J Toxicol Environ Health A. 65:843–852. 2002. View Article : Google Scholar
26	Gong P and Cederbaum AI: Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1. Hepatology. 43:144–153. 2006. View Article : Google Scholar : PubMed/NCBI
27	Aoki Y, Sato H, Nishimura N, Takahashi S, Itoh K and Yamamoto M: Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol Appl Pharmacol. 173:154–160. 2001. View Article : Google Scholar : PubMed/NCBI
28	Shatz M and Liscovitch M: Caveolin-1: a tumor-promoting role in human cancer. Int J Radiat Biol. 84:177–189. 2008. View Article : Google Scholar : PubMed/NCBI
29	Milde-Langosch K: The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer. 41:2449–2461. 2005. View Article : Google Scholar : PubMed/NCBI
30	Milde-Langosch K, Janke S, Wagner I, et al: Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility. Breast Cancer Res Treat. 107:337–347. 2008. View Article : Google Scholar : PubMed/NCBI
31	Syeed N, Husain SA, Abdullah S, Sameer AS, Chowdri NA, Nanda MS and Siddiqi MA: Caveolin-1 promotes mammary tumorigenesis: mutational profile of the Kashmiri population. Asian Pac J Cancer Prev. 11:689–696. 2010.PubMed/NCBI
32	Gasser S, Orsulic S, Brown EJ and Raulet DH: The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 436:1186–1190. 2005. View Article : Google Scholar : PubMed/NCBI
33	Del Toro-Arreola S, Arreygue-Garcia N, Aguilar-Lemarroy A, et al: MHC class I-related chain A and B ligands are differentially expressed in human cervical cancer cell lines. Cancer Cell Int. 11:152011.PubMed/NCBI
34	Fox CJ, Hammerman PS, Cinalli RM, Master SR, Chodosh LA and Thompson CB: The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev. 17:1841–1854. 2003. View Article : Google Scholar : PubMed/NCBI
35	Chen WW, Chan DC, Donald C, Lilly MB and Kraft AS: Pim family kinases enhance tumor growth of prostate cancer cells. Mol Cancer Res. 3:443–451. 2005. View Article : Google Scholar : PubMed/NCBI
36	Pratap J, Lian JB, Javed A, Barnes GL, van Wijnen AJ, Stein JL and Stein GS: Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev. 25:589–600. 2006. View Article : Google Scholar : PubMed/NCBI
37	Yanagida O, Kanai Y, Chairoungdua A, et al: Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta. 1514:291–302. 2001. View Article : Google Scholar : PubMed/NCBI
38	Nakanishi K, Matsuo H, Kanai Y, et al: LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Virchows Arch. 448:142–150. 2006. View Article : Google Scholar : PubMed/NCBI
39	White AR, Multhaup G, Galatis D, et al: Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer’s disease amyloid precursor protein. J Neurosci. 22:365–376. 2002.PubMed/NCBI
40	Tang X, Milyavsky M, Goldfinger N and Rotter V: Amyloid-beta precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress. Oncogene. 26:7302–7312. 2007. View Article : Google Scholar : PubMed/NCBI
41	Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD and Berger SL: p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol. 19:1202–1209. 1999.PubMed/NCBI
42	Lindsey-Boltz LA, Serçin O, Choi JH and Sancar A: Reconstitution of human claspin-mediated phosphorylation of Chk1 by the ATR (ataxia telangiectasia-mutated and rad3-related) checkpoint kinase. J Biol Chem. 284:33107–33114. 2009. View Article : Google Scholar : PubMed/NCBI
43	Praetorius-Ibba M, Wang QE, Wani G, El-Mahdy MA, Zhu Q, Qin S and Wani AA: Role of Claspin in regulation of nucleotide excision repair factor DDB2. DNA Repair. 6:578–587. 2007. View Article : Google Scholar : PubMed/NCBI
44	Chini CC and Chen J: Claspin, a regulator of Chk1 in DNA replication stress pathway. DNA Repair. 3:1033–1037. 2004. View Article : Google Scholar : PubMed/NCBI
45	Tajeddine N, Gala JL, Louis M, Van Schoor M, Tombal B and Gailly P: Tumor-associated antigen preferentially expressed antigen of melanoma (PRAME) induces caspase-independent cell death in vitro and reduces tumorigenicity in vivo. Cancer Res. 65:7348–7355. 2005. View Article : Google Scholar